PRIO - a prospective integrative oncology registry: trial protocol

Area of Science:

• Oncology
• Integrative Medicine
• Clinical Research

Background:

• Integrative Oncology (IO) use is increasing among cancer patients.
• Growing evidence supports IO, leading to its inclusion in national guidelines.
• Significant gaps in knowledge and evidence for IO persist.

Purpose of the Study:

• To establish the PRIO registry for evaluating integrative oncology measures in cancer patients.
• To collect comprehensive data on patient demographics, cancer characteristics, and IO utilization.
• To investigate patient-reported outcomes, including quality of life and satisfaction with healthcare.

Main Methods:

• Prospective data collection from oncological patients at the University Cancer Center Ulm.
• Inclusion of data on demographics, socioeconomic status, cancer disease, therapy, and IO measures.
• Planned expansion to additional study centers and regular registry evaluation.

Main Results:

• The PRIO registry provides a robust dataset for analyzing integrative oncology practices.
• Patient-reported outcome measures are incorporated to assess quality of life and healthcare satisfaction.
• The registry aims to enhance transparency and inform future research in integrative oncology.

Conclusions:

• The PRIO registry is a valuable tool for understanding integrative oncology in cancer care.
• Data from the registry will contribute to evidence-based guidelines and improved patient outcomes.
• The study emphasizes the need for continued research into integrative oncology's role in cancer treatment.